BG99054A - Mycobacterium vaccae for the treatment of continuous autoimmune conditions - Google Patents

Mycobacterium vaccae for the treatment of continuous autoimmune conditions

Info

Publication number
BG99054A
BG99054A BG99054A BG9905494A BG99054A BG 99054 A BG99054 A BG 99054A BG 99054 A BG99054 A BG 99054A BG 9905494 A BG9905494 A BG 9905494A BG 99054 A BG99054 A BG 99054A
Authority
BG
Bulgaria
Prior art keywords
treatment
continuous
mycobacterium vaccae
autoimmune conditions
vaccae
Prior art date
Application number
BG99054A
Other languages
Bulgarian (bg)
English (en)
Inventor
John Stanford
Graham Rook
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London filed Critical University College London
Publication of BG99054A publication Critical patent/BG99054A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Soil Working Implements (AREA)
  • Storage Of Fruits Or Vegetables (AREA)
BG99054A 1992-02-21 1994-09-21 Mycobacterium vaccae for the treatment of continuous autoimmune conditions BG99054A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929203814A GB9203814D0 (en) 1992-02-21 1992-02-21 Treatment of long term auto-immune conditions
PCT/GB1993/000351 WO1993016727A1 (en) 1992-02-21 1993-02-19 Mycobacterium vaccae for treatment of long term autoimmune conditions

Publications (1)

Publication Number Publication Date
BG99054A true BG99054A (en) 1995-08-28

Family

ID=10710862

Family Applications (1)

Application Number Title Priority Date Filing Date
BG99054A BG99054A (en) 1992-02-21 1994-09-21 Mycobacterium vaccae for the treatment of continuous autoimmune conditions

Country Status (24)

Country Link
US (1) US5885588A (de)
EP (2) EP0630259B1 (de)
JP (1) JPH07506093A (de)
KR (1) KR100275862B1 (de)
AT (2) ATE151641T1 (de)
AU (2) AU675421B2 (de)
BG (1) BG99054A (de)
BR (1) BR9305946A (de)
CA (1) CA2130117A1 (de)
CZ (1) CZ282651B6 (de)
DE (2) DE69328503T2 (de)
DK (2) DK0763361T3 (de)
ES (2) ES2104131T3 (de)
FI (1) FI943849A0 (de)
GB (1) GB9203814D0 (de)
GR (2) GR3024113T3 (de)
HU (1) HU218347B (de)
NO (1) NO311169B1 (de)
NZ (1) NZ249518A (de)
RO (1) RO117833B1 (de)
RU (1) RU2124367C1 (de)
SK (1) SK99994A3 (de)
UA (1) UA35583C2 (de)
WO (1) WO1993016727A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9406301D0 (en) * 1994-03-30 1994-05-25 Univ London Immunotherapeutic agent and its use
IL110011A (en) * 1994-06-13 2004-09-27 Yeda Res & Dev Pharmacological preparations for the treatment of schizophrenia
GB9505658D0 (en) * 1995-03-21 1995-05-10 Univ London Hormone and growth factor mimetics
US6056964A (en) * 1995-03-29 2000-05-02 Stanford Rook Limited Immunotherapeutic agent and its use
US6160093A (en) * 1996-08-29 2000-12-12 Genesis Researth And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
AU741016B2 (en) * 1996-08-29 2001-11-22 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6878377B2 (en) 1996-12-18 2005-04-12 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
KR100533818B1 (ko) * 1996-12-18 2005-12-07 스탠포드 룩 리미티드 면역계의 ｔｈ2 활성의 하향 조절을 위한 마이코박테리움 박케
RU2137137C1 (ru) * 1997-12-03 1999-09-10 Научно-исследовательский институт по изучению лепры Способ определения m.leprae у больных с регрессом заболевания
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
IL136821A0 (en) * 1997-12-23 2001-06-14 Genesis Res & Dev Corp Ltd Compositions derived from mycobacterium vaccae and methods for their use
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
WO2001010221A1 (en) * 1999-08-06 2001-02-15 Corixa Corporation Vaccines for the treatment of autoimmune disease
GB0010496D0 (en) * 2000-04-28 2000-06-14 Stanford Rook Ltd Treatment of conditions of the central nervous system
GB0106986D0 (en) * 2001-03-20 2001-05-09 Stanford Rook Ltd Immunotherapeutic agent
GB0106985D0 (en) * 2001-03-20 2001-05-09 Stanford Rook Ltd Immunotherapeutic agent
JP4875494B2 (ja) 2003-11-14 2012-02-15 ユーシーエル バイオメディカ ピーエルシー 免疫調節物質

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
CA2095855C (en) * 1990-11-08 2003-04-29 Graham A.W. Rook Mycobacterium as adjuvant for antigens

Also Published As

Publication number Publication date
WO1993016727A1 (en) 1993-09-02
DE69309915T2 (de) 1997-07-24
SK99994A3 (en) 1995-05-10
NZ249518A (en) 1997-07-27
DE69309915D1 (de) 1997-05-22
GR3024113T3 (en) 1997-10-31
EP0763361A3 (de) 1997-03-26
DK0763361T3 (da) 2000-08-07
DK0630259T3 (da) 1997-09-15
CZ202394A3 (en) 1995-02-15
CZ282651B6 (cs) 1997-08-13
DE69328503D1 (de) 2000-05-31
JPH07506093A (ja) 1995-07-06
ES2145968T3 (es) 2000-07-16
HU218347B (hu) 2000-08-28
NO943082L (no) 1994-10-17
DE69328503T2 (de) 2000-08-24
RU2124367C1 (ru) 1999-01-10
CA2130117A1 (en) 1993-09-02
AU3637793A (en) 1993-09-13
RU94045825A (ru) 1997-02-20
BR9305946A (pt) 1997-10-21
NO943082D0 (no) 1994-08-22
HUT69941A (en) 1995-09-28
ATE151641T1 (de) 1997-05-15
FI943849A0 (fi) 1994-08-22
UA35583C2 (uk) 2001-04-16
US5885588A (en) 1999-03-23
KR950700755A (ko) 1995-02-20
GR3033772T3 (en) 2000-10-31
AU7188796A (en) 1997-02-06
EP0630259A1 (de) 1994-12-28
GB9203814D0 (en) 1992-04-08
HU9402422D0 (en) 1994-10-28
EP0763361B1 (de) 2000-04-26
ES2104131T3 (es) 1997-10-01
EP0763361A2 (de) 1997-03-19
AU706122B2 (en) 1999-06-10
RO117833B1 (ro) 2002-08-30
AU675421B2 (en) 1997-02-06
NO311169B1 (no) 2001-10-22
ATE192046T1 (de) 2000-05-15
EP0630259B1 (de) 1997-04-16
KR100275862B1 (ko) 2000-12-15

Similar Documents

Publication Publication Date Title
BG99054A (en) Mycobacterium vaccae for the treatment of continuous autoimmune conditions
ZA954679B (en) Bicyclic compounds
EP0625991A4 (de) Verbesserte alpha-interferon-zusammensetzung und verfahren zu ihrer herstellung aus leukocyten des menschlichen peripheren blute.
NL300140I2 (nl) Galanthamine, of verbindingen die eraan analoog zijn, voor behandeling van de ziekte van Alzheimer.
UA27231C2 (uk) Застосування модафінілу як лікувального засобу, що має протиішемічну дію на церебральному рівні
BG107537A (bg) Инхибиране на човешка tnf алфа активност
MY111201A (en) New imidazopyridines
AU7164987A (en) Treatment of sexual dysfunction with buspirone
GR3036691T3 (en) Dna sequences related to isolated fragile x syndrome
ES529170A0 (es) El agente antitumoral rebecamicina
HU9500933D0 (en) Use of il-10 to prevent or treat insulin-dependent diabetes mellitus
MY104070A (en) Cyclopropane derivatives
ZA873765B (en) Fixing system for fastening catheters,cannulas or the like to the skin surface and process for the sterile fastening thereof
CH612160A5 (en) Process for the biological purification of effluent
FR2689518B1 (fr) Microorganismes, procédé de préparation et utilisation.
EP0273310A3 (de) 5-Aryl-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva
EP0457671A3 (en) Dipyridamide for the treatment of diseases of the central or peripheral nervous system
DE3780191D1 (de) Octahydroindolizine analgesica und 7-keto-zwischenprodukte.
IL138636A0 (en) Purification of carboxaldehyde
PL334093A1 (en) Application of comt inhibitors in production of drugs preventing occurence of vascular disorders in case of diabetes
GR3001850T3 (en) Expellants of phytopathogenic microbes
IE781396L (en) Purification of mercaptobenzothiazole
ES2024364A6 (es) Procedimiento mejorado para purificar banos de deposicion de niquel.
MY125496A (en) Rubber product
DE3661822D1 (en) Alcohols and esters from the reaction of butadiene with magnesium and alkyl halogenides, their production and their use as perfumes